Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice
BPC-157 functions as a signaling peptide, activating healing pathways where injury already exists
Vitamin B12 Frequency Options Single Boost Perfect for occasional energy support: Event Preparation: Ideal before important events or busy periods Travel Recovery: Helps combat jet lag and travel fatigue Seasonal Support: Provides extra support during challenging seasons Regular Maintenance Optimal for ongoing wellness support: Weekly Sessions: Maximum support for significant deficiencies Bi-weekly Options: Balanced maintenance for most individuals Monthly Maintenance: Consistent support for preventative care Simple Tips for Before and After For optimal B12 injection results: Before Coming In: Stay well-hydrated on the day of your appointment
Protocol compliance affects outcomes substantially
For a full look at IV, injection, and program options, visit our NAD+ therapy in Sioux Falls page

What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling
